OGD/OND system will help share reviews
The Office of Generic Drugs is adopting a new information technology system that will enable it to share reviews with the Office of New Drugs, allowing both offices "full access to all available information of approved drug products," FDA announces Oct. 6. The new electronic Division File System provides OGD "document management, tracking, archiving, and electronic signature capabilities for internally generated review documents and search and retrieval capabilities for final versions of internally generated documents." FDA hopes the improved electronic repository for ANDA review and regulatory documents will improve the efficiency of the generic review process; OGD's mounting application backlog has come under fire over the last year (1"The Pink Sheet" Feb. 13, 2006, p. 7)...
You may also be interested in...
FDA is reducing the percentage of generic drug applications for which it aims to shorten review time
Royal Philips will make 43,000 medical ventilators by year-end for use in the US and make 2,500 more for the Strategic National Stockpile in a deal with the US government worth $646.7m. See what Philips’ CEO Frans van Houten said about it here.
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.